8 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... #AACE #2018 # ... Glycemic #Diabetes ... #DM2 #Control # ... Medication #Algorithm
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... - AACE 2018 ... #Antidiabetic #Medications ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology
Diabetes Medication Prescribing Algorithm

- Dr. Eric Strong @DrEricStrong - Strong Medicine https://www.youtube.com/c/EricsMedicalLectures/featured

#Diabetes #Medications #Prescribing #Algorithm #management
Diabetes Medication ... Prescribing Algorithm ... #Algorithm #management ... #endocrinology ... #dm2
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Diabetes Type 2 ... Medication Management ... and Titration Algorithm ... #DM2 #Type2 #Medication ... #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... #medications #table ... #comparison #management ... #endocrinology ... #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... #Mellitus #DM2 ... #Inpatient #Medications ... #pharmacology #comparison ... #table #endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... medications, with ... being approved in 2013 ... #DM2 #Diabetes ... #Endocrinology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... Insulin dependent DM ... event, follow ACC algorithm ... Diabetes regimen ... PCI/DES ( Levine 2016